Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders

NCT00036127 is registered in ClinicalTrials.gov with Otsuka Pharmaceutical Development & Commercialization, Inc. as lead sponsor.

NCT NCT00036127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2002
Completion date
January 31, 2003
Enrollment
Not reported
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia